Neurology News

WEST PALM BEACH, Fla. — Advanced diagnostic tools aid in the distinction between radiologically isolated syndrome and MS prodrome, according to a presenter at the ACTRIMS Forum.

WEST PALM BEACH, Florida — Autologous hematopoietic stem cell transplantation had long-term effectiveness for treating aggressive MS, according to results of a retrospective observational study presented at the ACTRIMS Forum.

WEST PALM BEACH, Florida — Input of baseline characteristics into deep learning machines can reveal subgroups of patients who respond to disease-modifying therapies for primary progressive MS, per a presentation at the ACTRIMS Forum.

The Senate recently passed a bill to address the stigma that health care professionals often face when seeking mental health services.

Intensive anti-seizure treatment suppressing rhythmic and periodic electroencephalographic patterns in comatose survivors of cardiac arrest did not result in fewer poor outcomes at 3 months vs. standard treatment, researchers reported.

The FDA has granted an investigational new drug application to 4D pharma plc for two live biotherapeutics to treat Parkinson’s disease, according to a company release.

Medical device company Precisis GmbH announced its EASEE brain stimulator has received breakthrough device designation from the FDA, according to a press release.

Growing evidence suggests that music therapy can be an effective method for relieving pain, according to researchers.

In a company release, Horizon Therapeutics announced results from a phase 2/3 trial demonstrating that its B-cell-depleting agent Uplizna reduced the severity of attacks in people with neuromyelitis optica spectrum disorder.

Surgical therapy yielded lower long-term health care costs compared with medical therapy in children with drug-resistant epilepsy, according to a Canadian study published in Neurology.